Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study - PubMed (original) (raw)
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study
P Rossing et al. BMJ. 1996.
Abstract
Objective: To evaluate the prognostic significance of microalbuminuria and overt diabetic nephropathy and other putative risk factors for cardiovascular and all cause mortality in insulin dependent diabetes.
Design: Ten year observational follow up study.
Setting: Outpatient diabetic clinic in a tertiary referral centre.
Subjects: All 939 adults with insulin dependent diabetes (duration of diabetes five years or more) attending the clinic in 1984; 593 had normal urinary albumin excretion (< or = 30 mg/24 h), 181 persistent microalbuminuria (31-299 mg/24 h), and 165 overt nephropathy (> or = 300 mg/24 h).
Main outcome measure: All cause and cardiovascular mortality.
Results: Fifteen per cent of patients (90/593) with normoalbuminuria, 25% (45/181) with microalbuminuria, and 44% (72/165) with overt nephropathy at baseline died during follow up. Cox multiple regression analysis identified the following significant predictors of all cause mortality: male sex (relative risk 2.03; 95% confidence interval 1.37 to 3.02), age (1.07; 1.06 to 1.08), height (0.96; 0.94 to 0.98), smoking (1.51; 1.09 to 2.08), social class V versus social class IV (1.70; 1.25 to 2.31), log10 urinary albumin excretion (1.45; 1.18 to 1.77), hypertension (1.63; 1.18 to 2.25), log10 serum creatinine concentration (8.96; 3.34 to 24.08), and haemoglobin A1c concentration (1.11; 1.03 to 1.20). Age, smoking, microalbuminuria, overt nephropathy, and hypertension were significant predictors of cardiovascular mortality. Mortality in patients with microalbuminuria was only slightly increased compared with that in patients with normoalbuminuria. Median survival time after the onset of overt diabetic nephropathy was 13.9 years (95% confidence interval 11.8 to 17.2 years).
Conclusions: Abnormally increased urinary albumin excretion and other potentially modifiable risk factors such as hypertension, smoking, poor glycaemic control, and social class predict increased mortality in insulin dependent diabetes. Microalbuminuria by itself confers only a small increase in mortality. The prognosis of patients with overt diabetic nephropathy has improved, probably owing to effective antihypertensive treatment.
Similar articles
- [Risk factors for mortality in patients with insulin-dependent diabetes].
Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Rossing P, et al. Ugeskr Laeger. 1998 Feb 23;160(9):1315-9. Ugeskr Laeger. 1998. PMID: 9495080 Danish. - Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study.
Gall MA, Hougaard P, Borch-Johnsen K, Parving HH. Gall MA, et al. BMJ. 1997 Mar 15;314(7083):783-8. doi: 10.1136/bmj.314.7083.783. BMJ. 1997. PMID: 9080995 Free PMC article. - Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration.
Forsblom CM, Groop PH, Ekstrand A, Groop LC. Forsblom CM, et al. BMJ. 1992 Oct 31;305(6861):1051-3. doi: 10.1136/bmj.305.6861.1051. BMJ. 1992. PMID: 1467683 Free PMC article. - [Microalbuminuria in diabetes mellitus--illness or symptom?].
Müller WA. Müller WA. Versicherungsmedizin. 1996 Jun 1;48(3):70-6. Versicherungsmedizin. 1996. PMID: 8737541 Review. German. - Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
Lewis EJ, Lewis JB. Lewis EJ, et al. Clin Exp Nephrol. 2003 Mar;7(1):1-8. doi: 10.1007/s101570300000. Clin Exp Nephrol. 2003. PMID: 14586737 Review.
Cited by
- Esm-1 mediates transcriptional polarization associated with diabetic kidney disease.
Gaudet A, Zheng X, Kambham N, Bhalla V. Gaudet A, et al. Am J Physiol Renal Physiol. 2024 Jun 1;326(6):F1016-F1031. doi: 10.1152/ajprenal.00419.2023. Epub 2024 Apr 11. Am J Physiol Renal Physiol. 2024. PMID: 38601985 - Patients with type 1 diabetes and albuminuria have a reduced brain glycolytic capability that is correlated with brain atrophy.
Vestergaard MB, Laursen JC, Heinrich NS, Rossing P, Hansen TW, Larsson HBW. Vestergaard MB, et al. Front Neurosci. 2023 Oct 5;17:1229509. doi: 10.3389/fnins.2023.1229509. eCollection 2023. Front Neurosci. 2023. PMID: 37869511 Free PMC article. - Pancreatic transplant surgery and stem cell therapy: Finding the balance between therapeutic advances and ethical principles.
Padovano M, Scopetti M, Manetti F, Morena D, Radaelli D, D'Errico S, Di Fazio N, Frati P, Fineschi V. Padovano M, et al. World J Stem Cells. 2022 Aug 26;14(8):577-586. doi: 10.4252/wjsc.v14.i8.577. World J Stem Cells. 2022. PMID: 36157914 Free PMC article. Review. - Diagnostic and therapeutic characteristics of diabetes mellitus and risk of out-of-hospital cardiac arrest.
Park JH, Ro YS, Shin SD, Cha KC, Song KJ, Hwang SO; phase II Cardiac Arrest Pursuit Trial with Unique Registry and Epidemiologic Surveillance (CAPTURES-II) investigators. Park JH, et al. Sci Rep. 2022 Jan 25;12(1):1293. doi: 10.1038/s41598-022-05390-w. Sci Rep. 2022. PMID: 35079073 Free PMC article. - All-cause and cardiovascular disease mortality in underweight patients with diabetic nephropathy: BioBank Japan cohort.
Yokomichi H, Mochizuki M, Hirata M, Nagai A, Kojima R, Horiuchi S, Ooka T, Akiyama Y, Shinohara R, Miyake K; BioBank Japan Project; Yamagata Z. Yokomichi H, et al. J Diabetes Investig. 2021 Aug;12(8):1425-1429. doi: 10.1111/jdi.13483. Epub 2021 Jan 18. J Diabetes Investig. 2021. PMID: 33340268 Free PMC article.
References
- Diabetologia. 1985 Aug;28(8):590-6 - PubMed
- Am J Med. 1985 May;78(5):785-94 - PubMed
- Am J Cardiol. 1987 Apr 1;59(8):750-5 - PubMed
- Diabet Med. 1984 May;1(1):17-9 - PubMed
- Br Med J (Clin Res Ed). 1988 Jan 16;296(6616):156-60 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical